Table 3.

Logistic regression results for the odds of adhering to prevention of mother-to-child transmission (PMTCT) protocols by type and severity of intimate partner violence.

Factor:	cART adherence >80% during pregnancy (n=271) ¹	Took sdNVP during childbirth (n=131) ¹	cART adherence >80% during postpartum (n=285) ¹	Infant NVP prophylaxis adherence >80% during postpartum (n=303) ¹

Emotional IPV	0.43 (0.17 – 1.06)	0.37 (0.08 – 1.82)	0.10^*** (0.03 – 0.36)	0.10^*** (0.04 – 0.26)
Physical IPV	0.90 (0.36 – 2.27)	0.95 (0.22 – 4.18)	0.65 (0.24 – 1.72)	0.38^* (0.18 – 0.80)
Sexual IPV	0.32^* (0.13 – 0.80)	0.17^* (0.03 – 0.92)	0.26^** (0.10 – 0.72)	0.34^** (0.16 – 0.71)
Mean number of IPV events	0.80^* (0.66 – 0.98)	0.80 (0.58 – 1.13)	0.69^** (0.56 – 0.86)	0.68^*** (0.57 – 0.81)
Injuries from IPV (n=157) ³	0.78 (0.22 – 2.74)	0.56 (0.08 – 4.12)	0.62 (0.15 – 2.55	0.28^* (0.09 – 0.85)

Notes. Logistic regression results are presented as adjusted odds ratios and 95% confidence intervals; Adjusted for mother’s age, infant’s age, education, parity, knowledge of PMTCT, number of household assets, PMTCT regimen, and HIV status disclosure to husband/partner. Abbr. cART=Combination antiretroviral therapy. IVP=Intimate partner violence. NVP=Nevirapine. PMTCT=Prevention of mother-to-child transmission. sdNVP=Single dose NVP.

Different sample size because women were offered medication differentially for each protocol

Adjusting for mother’s age, infant’s age, education, parity, knowledge of PMTCT, number of household assets, PMTCT regimen, and HIV status disclosure to husband/partner

Of the women who reported experiencing physical/sexual violence

p<0.05

^**

p<0.01

^***

p<0.001 level of significant difference